STE vs. BRKR

Last updated Jun 3, 2026

STE (STERIS plc) and BRKR (Bruker Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, STE returned 12.72%/yr vs 8.50%/yr for BRKR. At a 0.37 correlation, their price movements are largely independent.

Performance

STE vs. BRKR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in STERIS plc (STE) and Bruker Corporation (BRKR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, STE achieves a -17.05% return, which is significantly lower than BRKR's 21.83% return. Over the past 10 years, STE has outperformed BRKR with an annualized return of 12.72%, while BRKR has yielded a comparatively lower 8.50% annualized return.

STE

• 1D: -0.62%
• 1M: -2.16%
• YTD: -17.05%
• 6M: -18.90%
• 1Y: -12.48%
• 3Y*: 1.68%
• 5Y*: 2.92%
• 10Y*: 12.72%

BRKR

• 1D: -1.93%
• 1M: 55.78%
• YTD: 21.83%
• 6M: 21.50%
• 1Y: 56.87%
• 3Y*: -6.72%
• 5Y*: -3.20%
• 10Y*: 8.50%

*Multi-year figures are annualized to reflect compound growth (CAGR)

STE vs. BRKR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
STE STERIS plc	-17.05%	24.57%	-5.60%	20.19%	-23.43%	29.47%	25.50%	44.09%	23.66%	31.73%
BRKR Bruker Corporation	21.83%	-19.24%	-19.99%	7.82%	-18.29%	55.35%	6.58%	71.85%	-12.82%	62.96%

Correlation

The correlation between STE and BRKR is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.32
Correlation (3Y) Calculated over the trailing 3-year period	0.39
Correlation (5Y) Calculated over the trailing 5-year period	0.44
Correlation (10Y) Calculated over the trailing 10-year period	0.46
Correlation (All Time) Calculated using the full available price history since Aug 7, 2000	0.37

The correlation between STE and BRKR shifts across timeframes, from 0.32 (1 year) to 0.46 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap STE : $20.64B BRKR : $8.75B
EPS STE : $7.93 BRKR : -$0.17
PS Ratio STE : 3.49 BRKR : 2.52
PB Ratio STE : 2.87 BRKR : 3.55
Total Revenue (TTM) STE : $5.94B BRKR : $3.46B
Gross Profit (TTM) STE : $2.63B BRKR : $1.57B
EBITDA (TTM) STE : $1.34B BRKR : $224.20M

Return for Risk

STE vs. BRKR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STE

STE Risk / Return Rank: 16
STE Sharpe Ratio Rank: 17
STE Sortino Ratio Rank: 17
STE Omega Ratio Rank: 17
STE Calmar Ratio Rank: 21
STE Martin Ratio Rank: 8

BRKR

BRKR Risk / Return Rank: 67
BRKR Sharpe Ratio Rank: 72
BRKR Sortino Ratio Rank: 68
BRKR Omega Ratio Rank: 66
BRKR Calmar Ratio Rank: 67
BRKR Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STE vs. BRKR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for STERIS plc (STE) and Bruker Corporation (BRKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	STE	BRKR	Difference
Sharpe ratio Return per unit of total volatility	-0.53	1.06	-1.59
Sortino ratio Return per unit of downside risk	-0.63	1.65	-2.28
Omega ratio Gain probability vs. loss probability	0.92	1.20	-0.28
Calmar ratio Return relative to maximum drawdown	-0.55	1.43	-1.98
Martin ratio Return relative to average drawdown	-1.36	2.78	-4.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

STE vs. BRKR - Sharpe Ratio Comparison

The current STE Sharpe Ratio is -0.53, which is lower than the BRKR Sharpe Ratio of 1.06. The chart below compares the historical Sharpe Ratios of STE and BRKR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	STE	BRKR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.53	1.06	-1.59
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	-0.08	+0.19
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	0.23	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.07	+0.34

Drawdowns

STE vs. BRKR - Drawdown Comparison

The maximum STE drawdown since its inception was -77.22%, smaller than the maximum BRKR drawdown of -94.83%. Use the drawdown chart below to compare losses from any high point for STE and BRKR.

Drawdown Indicators

	STE	BRKR	Difference
Max Drawdown Largest peak-to-trough decline	-77.22%	-94.83%	+17.61%
Max Drawdown (1Y) Largest decline over 1 year	-24.67%	-39.85%	+15.18%
Max Drawdown (3Y) Largest decline over 3 years	-24.67%	-68.72%	+44.05%
Max Drawdown (5Y) Largest decline over 5 years	-36.18%	-68.72%	+32.54%
Max Drawdown (10Y) Largest decline over 10 years	-36.18%	-68.72%	+32.54%
Current Drawdown Current decline from peak	-21.72%	-38.67%	+16.95%
Average Drawdown Average peak-to-trough decline	-18.32%	-57.72%	+39.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.00%	20.48%	-10.48%

Volatility

STE vs. BRKR - Volatility Comparison

The current volatility for STERIS plc (STE) is 7.80%, while Bruker Corporation (BRKR) has a volatility of 18.17%. This indicates that STE experiences smaller price fluctuations and is considered to be less risky than BRKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	STE	BRKR	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.80%	18.17%	-10.37%
Volatility (6M) Calculated over the trailing 6-month period	18.17%	37.22%	-19.05%
Volatility (1Y) Calculated over the trailing 1-year period	23.71%	53.87%	-30.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.79%	41.15%	-15.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.07%	37.55%	-12.48%

Dividends

STE vs. BRKR - Dividend Comparison

STE's dividend yield for the trailing twelve months is around 1.17%, more than BRKR's 0.35% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BRKR Bruker Corporation	0.35%	0.42%	0.34%	0.27%	0.29%	0.19%	0.30%	0.31%	0.54%	0.47%	0.76%	0.00%
STE STERIS plc	1.17%	0.95%	1.06%	0.90%	0.97%	0.68%	0.81%	0.93%	1.22%	1.35%	1.57%	1.27%

Financials

STE vs. BRKR - Profitability Comparison

The chart below illustrates the profitability comparison between STERIS plc and Bruker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

STE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, STERIS plc reported a gross profit of 697.10M and revenue of 1.59B. Therefore, the gross margin over that period was 43.9%.

BRKR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a gross profit of 379.80M and revenue of 823.40M. Therefore, the gross margin over that period was 46.1%.

STE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, STERIS plc reported an operating income of 316.80M and revenue of 1.59B, resulting in an operating margin of 19.9%.

BRKR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported an operating income of 10.20M and revenue of 823.40M, resulting in an operating margin of 1.2%.

STE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, STERIS plc reported a net income of 220.30M and revenue of 1.59B, resulting in a net margin of 13.9%.

BRKR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a net income of 0.00 and revenue of 823.40M, resulting in a net margin of 0.0%.

Frequently Asked Questions

Can I hold both STE and BRKR in my portfolio?

STE and BRKR have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, STE or BRKR?

BRKR has higher volatility (18.17%) compared to STE (7.80%). In terms of maximum drawdown, STE dropped -77.22% vs BRKR's -94.83%.

Which has better risk-adjusted returns?

BRKR currently has the higher Sharpe Ratio (1.06 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.